Vimal Mehta, Ph.D.
Chief Executive Officer & Founder
Dr. Mehta brings over two decades of experience in the pharma and biotech industry, during which he has successfully designed and implemented innovative solutions, established global commercial operations, and led cross-functional teams. During his career, he has garnered a deep understanding of
Richard I. Steinhart
Senior Vice President and Chief Financial Officer
Richard Steinhart brings significant financial and strategic experience in the biotechnology and medical device industries. Prior to joining BioXcel Therapeutics, Richard served as Vice President and CFO at Remedy Pharmaceuticals, Inc., until it sold its only asset, CIRARA, to Biogen for $120M plus
Frank D. Yocca, Ph.D.
Chief Scientific Officer
Dr. Frank Yocca is an accomplished R&D executive and scientist with extensive experience leading global biopharmaceutical companies. He has wide-ranging expertise in leading high-performing, world-class teams in drug discovery and development whose efforts have resulted in a number of prominent
Chetan D. Lathia, Ph.D.
Senior Vice President and Head of Translational Medicine, Clinical Pharmacology and Regulatory Affairs
Dr. Chetan Lathia has more than 30 years of experience in clinical pharmacology, translational medicine nonclinical development, and regulatory affairs at both large and small biopharma companies. He has co-led over 25 Investigational New Drug (IND) applications and 10 New Drug Applications
Vincent J. O’Neill M.D.
Senior Vice President & Chief Medical Officer
Dr. Vince O’Neill has expertise in therapeutic and diagnostic product development and has held senior leadership roles at global pharmaceutical companies, including Sanofi, Genentech, and GlaxoSmithKline. Most recently, he served as Chief Medical Officer at Mirna Therapeutics and Exosome
Robert Risinger, M.D.
Chief Medical Officer, Neuroscience
Dr. Rob Risinger has extensive experience leading clinical development from first in human through Phase 1-4 clinical trials to create a successful commercial product. His expertise includes designing and executing high quality translational studies within Phase 1 and 2 that provide insight and
Senior Vice President, Chief Legal Officer, and Corporate Secretary
Javier Rodriguez has over 20 years of extensive strategic and legal experience within the biopharmaceutical industry. Prior to joining BioXcel Therapeutics, he served as Chief Legal Officer at Indivior PLC, where he oversaw legal affairs, data privacy compliance and corporate governance matters for
Senior Vice President and Chief Commercial Officer
Matt Wiley has over 25 years of sales, marketing, and strategy experience across multiple specialty product launches. Prior to joining BioXcel Therapeutics, he served as Chief Commercial Officer at VYNE Therapeutics, overseeing all commercial objectives related to the launch of the company’s first